Candelasa, Cleofe H.
HRN: 21-37-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CEFUROXIME 1.5GM (VIAL)
05/23/2022
05/23/2022
IV
1.5gm
1 Dose
Loading Dose For TAHBSO W/ VAGINAL MYOMECTOMY
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes